Scientists in Scotland discovered the medications, which target cells that activate vitamin A, may be therapeutic for ...

Scientists in Scotland discovered medications, which target specific receptors, may be therapeutic for diseases that lead to ...

Both Adzenys and Adderall are stimulant-based drugs that target neurotransmitters in the brain, but there are some ...

Columnist Juliet Taylor reflects on how the power of music helped her and her late husband, Jeff, navigate the difficulties ...

H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on Cytokinetics (CYTK – Research Report) today and set a price target of ...

There is currently no cure for MND or any treatment which can improve symptoms for more than a few months. Newly published research led by ...

Drugs that switch on vitamin A in the body may also help stave off conditions such as motor neurone disease (MND), raising ...

It's gained greater awareness, thanks to grass roots initiatives. Learn about ALS based on a patient's experience and a ...

The biopharmaceutical company is focusing on a new drug after releasing disappointing data from an Alzheimer's drug earlier ...

ATH-1105 is an orally delivered, positive modulator of the neurotrophic HGF system that is currently in a Phase 1 clinical trial with completion ...

Ractigen's therapy candidate RAG-17 was safe across all tested doses and showed early signs of effectiveness in SOD1-ALS ...

PharmAust (ASX:PAA) has submitted a request for OMPD to the European Medicines Agency (EMA) for its lead drug monepantel.